Table 1 Demographic and clinical variables in the study subjects
From: Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life
Variable | Mean (±SD) | Minimum | Maximum | |
|---|---|---|---|---|
Age (years) | 36.35 ± 7.33 | 22.00 | 50.00 | |
Duration of marriage (years) | 15.07 ± 8.55 | 0.16 | 33.00 | |
Disease duration (years) | 7.37 ± 5.40 | 0.02 | 26 | |
Age at diagnosis (years) | 27.92 ± 7.57 | 11.00 | 49.50 | |
EDSS | 2.06 ± 1.85 | 0.00 | 7.50 | |
Fatigue | 3.65 ± 1.57 | 1.00 | 7.00 | |
Anxiety | 13.18(9.18) | 0 | 20 | |
Depression | 13.46(9.57) | 0 | 28 | |
Stress | 19.59(10.03) | 0 | 34 | |
QOL | Physical health composite score | 62.66 ± 19.15 | 15.42 | 96.24 |
Mental health composite score | 60.75 ± 19.99 | 9.07 | 97.34 | |
Education N (%) | Secondary school or below | 74 (24.7) | ||
High school | 132 (44.0) | |||
University | 94 (31.3) | |||
Occupation N (%) | Housewife | 258 (86.0) | ||
Employed | 33 (11.0) | |||
Retired | 9 (3.0) | |||
Disease pattern N (%) | Relapsing-Remitting MS (RRMS) | 243 (81.0) | ||
Progressive MS | 39 (13.0) | |||
Clinically Isolated Syndrome (CIS) | 18 (6.0) | |||
Taking medications N (%) | No | 30 (10.0) | ||
Yes 270 (90.0) | Disease Modifying Therapy (DMT) | 141 (47.0) | ||
Anticholinergic drugs | 51 (17.0) | |||
Psychiatric drugs | 8 (2.7) | |||
Antidepressants drugs | 56(18.7) | |||
Benzodiazepines drugs | 18(6.0) | |||
Anticonvulsants drugs | 50(16.7) | |||
| Â | Â | Beta blockers drugs | 17 (5.7) | |
Antispasmodic drugs (baclofen,tizanidine, Methocarbamol) | 38(12.7) | |||
Complementary drugs | 183 (61.0) | |||